NCCN Expands Focus on Quality of Life and Supportive Care with New Guides for People with Cancer

National Comprehensive Cancer Network publishes free NCCN Guidelines for Patients with information on improving well-being and reducing suffering and distress for people with cancer; available at NCCN.org/patientguidelines.

NCCN Releases New Resource to Help Families Understand Pediatric Hodgkin Lymphoma, Part of Award-Winning Patient Information Series

The National Comprehensive Cancer Network (NCCN) today announces the publication of NCCN Guidelines for Patients: Hodgkin Lymphoma in Children.

NCCN Publishes New Resource to Help Patients Understand Quick-Moving Type of Breast Cancer

NCCN has published a new addition to its library of patient resources, expanding the information available for breast cancer. The new NCCN Guidelines for Patients: Inflammatory Breast Cancer joins patient and caregiver resources for Breast Cancer Screening and Diagnosis, Ductal Carcinoma In Situ, Invasive Breast Cancer, and Metastatic Breast Cancer.

Four Early-Career Cancer Researchers Earn Prestigious Annual Award from NCCN Foundation

The National Comprehensive Cancer Network (NCCN) and the NCCN Foundation announce four winners for the 2023 NCCN Foundation Young Investigator Awards. These annual awards honor up-and-coming leaders in oncology research working to investigate and advance cancer care.

NCCN Guidelines for Patients Win Award for Excellence in Cancer Patient Education from CPEN

The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers devoted to patient care, research, and education—has been named winner for the 2022 Excellence in Cancer Patient Education award from the Cancer Patient Education Network (CPEN).

NCCN’s New Patient Guidelines for Marginal Zone Lymphoma Help Patients and Caregivers Better Understand a Rare Form of Blood Cancer

The new patient guidelines for Marginal Zone Lymphoma guidelines are the latest in NCCN’s library of NCCN Guidelines for Patients®, published through funding from the NCCN Foundation® and available online free of charge.

NCCN Foundation Announces Awards for Rising Cancer Research Leaders

National Comprehensive Cancer Network’s Oncology Research Program to oversee projects from early-career investigators advancing key areas for study in cancer care and biology, such as novel combination therapy, equitable access to cellular therapies, immune cell dysfunction, liquid biomarkers, genetic ancestry, oncogenic vulnerabilities, and MAIT cell antitumor activity.

New Patient Guide from NCCN Jumpstarts Important Conversations About Anal Cancer

New and updated patient and caregiver resources from National Comprehensive Cancer Network (NCCN) offer jargon-free, state-of-the-art information on diagnosis, treatment, and surveillance for anal, colon, and rectal cancers.

NCCN Foundation Announces Awards for Rising Cancer Research Leaders

National Comprehensive Cancer Network announces recipients of 2021 NCCN Foundation Young Investigator Awards; projects from early-career investigators to advance research in cancer prevention, racial disparities in screening, immunotherapy, new insights in radiotherapy, and CAR T-cell therapy.

Patrick Delaney Named New Executive Director of NCCN Foundation

The National Comprehensive Cancer Network® (NCCN®) today announced the appointment of Patrick Delaney as incoming Executive Director for the NCCN Foundation®. Delaney has previously held leadership roles with the Juvenile Diabetes Research Foundation, American Red Cross, and American Cancer Society.

New Resource for Survivors from NCCN Helps Guide Life After Cancer Diagnosis and Treatment

NCCN announces the publication of new, free informational resources on health and wellness for cancer survivors. Two new NCCN Guidelines for Patients® focus on healthy living and managing late and long-term side effects, and include appropriate ongoing screening for recurrence.

New NCCN Resource for Understanding Childhood Leukemia

NCCN publishes a new patient and caregiver resource focused on a childhood cancer type. Free NCCN Guidelines for Patients: Pediatric Acute Lymphoblastic Leukemia (ALL) shares the latest expert advice for treating infants, children, and adolescents with the most common pediatric malignancy.

NCCN: What People with Cancer and their Caregivers Need to Know about CAR T-Cell Therapy

The National Comprehensive Cancer Network (NCCN) has published a new NCCN Guidelines for Patients: Immunotherapy Side Effects focused on chimeric antigen receptor (CAR) T-cell therapy. This is book two in a series that includes another book on irAEs focused on immune checkpoint inhibitors.

How to Recognize Side-Effects from Immunotherapy? New NCCN Guidelines for Patients can Help

New NCCN Guidelines for Patients: Immunotherapy Side Effects – Immune Checkpoint Inhibitors from National Comprehensive Cancer Network and NCCN Foundation shares information for patients and caregivers on how to recognize and manage adverse events from immune checkpoint inhibitors.

New Information from NCCN on Overcoming Challenges for People with Head and Neck Cancers

Newly-completed series of patient guidelines from National Comprehensive Cancer Network (NCCN) shares expert advice with patients and caregivers on treatment and prevention for most common head and neck cancers, including some that are HPV-related.

NCCN Prostate Cancer Patient Guidelines Listed among Top Global Sources for Trustworthy Online Information

A recently-published, independent, peer-reviewed, international study in Current Urology measured reliability and transparency of online medical information for people with prostate cancer and their caregivers, and found the NCCN Guidelines for Patients® to be one of the most trustworthy resources.

NCCN

New Patient Resource from NCCN Helps People with Bladder Cancer Make Informed Treatment Decisions

New NCCN Guidelines for Patients: Bladder Cancer explains the lengthy surveillance process that follows active treatment for the sixth most-common cancer in the United States. PLYMOUTH MEETING, PA [June 26, 2019] — The treatment landscape for bladder cancer has changed…